SCOPUS 정보 검색 플랫폼

Volumn 37, Issue 3, 1999, Pages 792-795

Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA

(2) Erali, Maria a Hillyard, David R a,b,c

a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY (United States)

b UNIVERSITY OF UTAH SCHOOL OF MEDICINE (United States)

c ARUP LABORATORIES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MONITORING; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SAMPLING; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032993198 PISSN: 00951137 EISSN: None Source Type: Journal
DOI: 10.1128/jcm.37.3.792-795.1999 Document Type: Article

Times cited : (45)

References (8)

1
- 33748382285
- Use of ultra-sensitive PCR technology to provide insight into viral dynamics, abstr. 96
- St. Petersburg, Fla., 25 to 28 June 1998
- Conway, B., A. Shillington, S. Franses, et al. 1998. Use of ultra-sensitive PCR technology to provide insight into viral dynamics, abstr. 96. In Program and abstracts of the International Workshop on HIV Drug Resistance Treatment. Strategies, and Eradication, St. Petersburg, Fla., 25 to 28 June 1998.
- (1998) Program and Abstracts of the International Workshop on Hiv Drug Resistance Treatment. Strategies, and Eradication
- Conway, B.¹ Shillington, A.² Franses, S.³

2
- 0005920449
- Ultra sensitive detection of plasma HIV-1 RNA for predicting the durability of 3-drug antiretroviral therapy, abstr. 326
- Chicago, Ill., 2 to 4 February 1998
- Izopet, J., G. Salama, C. Pasquier, K. Sandres, E. Kuhlein, A. Blancher, B. Marchou, P. Massip, and J. Puel. 1998. Ultra sensitive detection of plasma HIV-1 RNA for predicting the durability of 3-drug antiretroviral therapy, abstr. 326. In Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, Ill., 2 to 4 February 1998.
- (1998) Program and Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections
- Izopet, J.¹ Salama, G.² Pasquier, C.³ Sandres, K.⁴ Kuhlein, E.⁵ Blancher, A.⁶ Marchou, B.⁷ Massip, P.⁸ Puel, J.⁹

3
- 1842296349
- + lymphocytes as prognostic markers of HIV-1 infection
- + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:945-954.
- (1997) Ann. Intern. Med. , vol.126 , pp. 945-954
- Mellors, J.W.¹ Munoz, A.² Giorgi, J.V.³ Margolick, J.B.⁴ Tassoni, C.J.⁵ Gupta, P.⁶ Kingsley, L.A.⁷ Todd, J.A.⁸ Saah, A.J.⁹ Detels, R.¹⁰ Phair, J.P.¹¹ Rinaldo, C.R.¹²

4
- 0031941327
- Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma
- Nolte, F. S., J. Boysza, C. Thurmond, W. S. Clark, and J. L. Lennox. 1998. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:716-720.
- (1998) J. Clin. Microbiol. , vol.36 , pp. 716-720
- Nolte, F.S.¹ Boysza, J.² Thurmond, C.³ Clark, W.S.⁴ Lennox, J.L.⁵

5
- 0031006111
- + lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure
- + lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann. Intern. Med. 126:939-945.
- (1997) Ann. Intern. Med. , vol.126 , pp. 939-945
- O'Brien, W.A.¹ Hartigan, P.M.² Daar, E.S.³ Simberkoff, M.S.⁴ Hamilton, J.D.⁵

6
- 0344881639
- Demographic and laboratory predictors of virologic treatment failures in patients achieving viral load reductions to below quantifiable levels (BQL) by Amplicor assay receiving indinavir +/-DMP 266 (efavirenz), abstr. 921
- Hamburg, Germany, 11 to 15 October 1997
- Ruiz, N. M., D. J. Manion, D. F. Labriola, P. A. Friedman, K. J. Gorelick, T. D. Saxton, A. P. Goldberg, G. Chao, and P. Jarrett and the DMF 266 Development Team. 1997. Demographic and laboratory predictors of virologic treatment failures in patients achieving viral load reductions to below quantifiable levels (BQL) by Amplicor assay receiving indinavir +/-DMP 266 (efavirenz), abstr. 921. In Program and abstracts of the 6th European Conference on Clinical Aspects and Treatment of HIV Infections. Hamburg, Germany, 11 to 15 October 1997.
- (1997) Program and Abstracts of the 6th European Conference on Clinical Aspects and Treatment of Hiv Infections
- Ruiz, N.M.¹ Manion, D.J.² Labriola, D.F.³ Friedman, P.A.⁴ Gorelick, K.J.⁵ Saxton, T.D.⁶ Goldberg, A.P.⁷ Chao, G.⁸ Jarrett, P.⁹

7
- 1842266562
- HIV viral load markers in clinical practice
- Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volberding. 1996. HIV viral load markers in clinical practice. Nat. Med. 2:625-629.
- (1996) Nat. Med. , vol.2 , pp. 625-629
- Saag, M.S.¹ Holodniy, M.² Kuritzkes, D.R.³ O'Brien, W.A.⁴ Coombs, R.⁵ Poscher, M.E.⁶ Jacobsen, D.M.⁷ Shaw, G.M.⁸ Richman, D.D.⁹ Volberding, P.A.¹⁰

8
- 0345312728
- Low HIV-1 RNA copy number assessed by bDNA and RT-PCR assays: Implications for managing patients above or below the viral RNA quantitation limit, abstr. 303
- Chicago, Ill., 1 to 5 February 1998
- Yerkovich, M., K. W. Ng, R. Sampoleo, J. Dragavon, and R. W. Coombs. 1998. Low HIV-1 RNA copy number assessed by bDNA and RT-PCR assays: implications for managing patients above or below the viral RNA quantitation limit, abstr. 303. In Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, Ill., 1 to 5 February 1998.
- (1998) Program and Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections
- Yerkovich, M.¹ Ng, K.W.² Sampoleo, R.³ Dragavon, J.⁴ Coombs, R.W.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.